Patent details

Basic Information

Publication number:

EP1327446

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP030060222

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

Controlled release oxycodone compositions

French Title of Invention:

Compositions d'oxycodone à libération contrôlée

German Title of Invention:

Oxycodonhaltige Arzneizusammensetzungen mit verzögerter Wirkstoffabgabe

SPC Number:

Dates

Filing date:

25/11/1992

Grant date:

17/03/2004

EP Publication Date:

17/03/2004

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

16/07/2003

EP B1 Publication Date:

17/03/2004

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

25/11/2012

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

21/06/2006

 

 

Name:

Mundipharma AB

Address:

Moindalsvagen 26, 412 63 Goteberg, Sweden (SE)

Name:

Mundipharma AG

Address:

St. Alban-Rheinweg 74, 4020 Basel, Switzerland (CH)

Name:

Mundipharma CVA

Address:

Campus Mechelen Schalienhoevedreef 20 H, 2800 Mechelen, Belgium (BE)

Name:

Mundipharma Farmaceutica LDA

Address:

Av. Eng. Duarte Pacheco Amoreias-Torre 1-15, 1070-101 Lisboa, Portugal (PT)

Name:

Mundipharma GesmbH

Address:

Apollogasse 16-18, 1072 Wien, Austria (AT)

Name:

Mundipharma GmbH

Address:

Mundipharma Strasse 2, 65549 Limburg, Germany (DE)

Name:

Mundipharma Laboratories GmbH

Address:

St. Alban-Rheinweg 74, 4020 Basel, Switzerland (CH)

Name:

Mundipharma Pharmaceuticals BV

Address:

Astronaut 36, 3824 MJ Amersfoort, Netherlands (NL)

Name:

Mundipharma Pharmaceuticals S.R.L.

Address:

Via G. Serbelloni 4, 20122 Milano, Italy (IT)

Name:

Mundipharma Pharmaceuticals SL

Address:

Velazquez 21 3 dcha, 28001 Madrid, Spain (ES)

Name:

Napp Pharmaceutical Holdings Limited

Address:

Cambridge Science Park Milton Road, Cambridge CB4 OGW, United Kingdom (GB)

Name:

Norpharma A/S

Address:

Slotsmarken 15, 2970 Horsholm, Denmark (DK)

Name:

The Purdue Pharma Company

Address:

One Stamford Forum, Stamford, CT 06901, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

17/06/2004

Address:

PO Box 48, 8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Minogue John Joseph

Address:

United States (US)

2

Name:

Kaiko Robert Francis

Address:

United States (US)

3

Name:

Chasin Mark

Address:

Japan (JP)

4

Name:

Oshlack Benjamin

Address:

United States (US)

Priority

Priority Number:

800549

Priority Date:

27/11/1991

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/485;

Filing date	Document type	Number of pages